Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses
Joep Beumer, Maarten H. Geurts, Mart M. Lamers, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 695
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 693-699
Open Access | Times Cited: 614
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 340-348
Open Access | Times Cited: 174
Human organoid models to study SARS-CoV-2 infection
Yuling Han, Liuliu Yang, Lauretta A. Lacko, et al.
Nature Methods (2022) Vol. 19, Iss. 4, pp. 418-428
Open Access | Times Cited: 99
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
Andrew C. Hunt, James Brett Case, Young‐Jun Park, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 646
Open Access | Times Cited: 98
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 70
CRISPR engineering in organoids for gene repair and disease modelling
Maarten H. Geurts, Hans Clevers
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 1, pp. 32-45
Open Access | Times Cited: 49
Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
Rosemary Millen, W. W. B. de Kort, Mandy Koomen, et al.
Med (2023) Vol. 4, Iss. 5, pp. 290-310.e12
Open Access | Times Cited: 47
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants
Cun Li, Jingjing Huang, Yifei Yu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 17
Open Access | Times Cited: 46
Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung
Ting-Hsuan Wu, Kyle J. Travaglini, Arjun Rustagi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 17
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
Judith M. White, Joshua T. Schiffer, Rachel Bender Ignacio, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 58
Limited extent and consequences of pancreatic SARS-CoV-2 infection
Verena van der Heide, Sonia Jangra, Phillip Cohen, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110508-110508
Open Access | Times Cited: 48
SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium
Mart M. Lamers, Anna Z. Mykytyn, Tim I. Breugem, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 47
Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review
Tina Sara Biju, Vishnu Priya Veeraraghavan, Arul Prakash Francis
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 9, pp. 2239-2253
Open Access | Times Cited: 34
Altered host protease determinants for SARS-CoV-2 Omicron
Jasper Fuk‐Woo Chan, Xiner Huang, Bingjie Hu, et al.
Science Advances (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 31
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 29
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models
Anna Z. Mykytyn, Tim I. Breugem, Maarten H. Geurts, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 27
Human norovirus cultivation systems and their use in antiviral research
Tsuyoshi Hayashi, Sakura Kobayashi, Junki Hirano, et al.
Journal of Virology (2024) Vol. 98, Iss. 4
Open Access | Times Cited: 10
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways
Laure‐Alix Clerbaux, Julija Filipovska, Amalia Muñoz, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5400-5400
Open Access | Times Cited: 29
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection
Bang M. Tran, Samantha L. Grimley, Julie McAuley, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 835-835
Open Access | Times Cited: 28
Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry
Qiyu Tong, Geng Liu, Xiongbo Sang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 1, pp. e1011131-e1011131
Open Access | Times Cited: 20
A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infection
Xuming Tang, Dongxiang Xue, Tuo Zhang, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 3, pp. 381-389
Open Access | Times Cited: 18
Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides
Yue Hu, Yuanmei Zhu, Yanying Yu, et al.
Antiviral Research (2023) Vol. 212, pp. 105571-105571
Open Access | Times Cited: 17
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility
Francesca Paola Luongo, Filippo Dragoni, Adele Boccuto, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1431-1431
Open Access | Times Cited: 24
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top